Effectiveness and safety of daclatasvir plus asunaprevir for patients with hepatitis C virus genotype 1b aged 75 years and over with or without cirrhosis (Q40689148)

From Wikidata
Jump to navigation Jump to search
scientific article published on 3 May 2016
edit
Language Label Description Also known as
English
Effectiveness and safety of daclatasvir plus asunaprevir for patients with hepatitis C virus genotype 1b aged 75 years and over with or without cirrhosis
scientific article published on 3 May 2016

    Statements

    Effectiveness and safety of daclatasvir plus asunaprevir for patients with hepatitis C virus genotype 1b aged 75 years and over with or without cirrhosis (English)
    Norihiro Furusyo
    Naoki Yamashita
    Kazuhiro Takahashi
    Kazufumi Dohmen
    Makoto Nakamuta
    Hideyuki Nomura
    Toshimasa Koyanagi
    Kazuhiro Kotoh
    Shinji Shimoda
    Kyushu University Liver Disease Study(KULDS) Group

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit